Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1989 1
1992 1
1994 1
1996 1
1997 6
1998 3
1999 4
2000 2
2001 3
2002 9
2003 12
2004 9
2005 9
2006 12
2007 27
2008 23
2009 21
2010 24
2011 19
2012 39
2013 72
2014 81
2015 98
2016 87
2017 92
2018 106
2019 144
2020 159
2021 220
2022 258
2023 237
2024 101

Text availability

Article attribute

Article type

Publication date

Search Results

1,686 results

Results by year

Filters applied: . Clear all
Page 1
Transarterial chemoembolization with PD-(L)1 inhibitors plus molecular targeted therapies for hepatocellular carcinoma (CHANCE001).
Zhu HD, Li HL, Huang MS, Yang WZ, Yin GW, Zhong BY, Sun JH, Jin ZC, Chen JJ, Ge NJ, Ding WB, Li WH, Huang JH, Mu W, Gu SZ, Li JP, Zhao H, Wen SW, Lei YM, Song YS, Yuan CW, Wang WD, Huang M, Zhao W, Wu JB, Wang S, Zhu X, Han JJ, Ren WX, Lu ZM, Xing WG, Fan Y, Lin HL, Zhang ZS, Xu GH, Hu WH, Tu Q, Su HY, Zheng CS, Chen Y, Zhao XY, Fang ZT, Wang Q, Zhao JW, Xu AB, Xu J, Wu QH, Niu HZ, Wang J, Dai F, Feng DP, Li QD, Shi RS, Li JR, Yang G, Shi HB, Ji JS, Liu YE, Cai Z, Yang P, Zhao Y, Zhu XL, Lu LG, Teng GJ; CHANCE001 Investigators. Zhu HD, et al. Among authors: liu ye. Signal Transduct Target Ther. 2023 Feb 8;8(1):58. doi: 10.1038/s41392-022-01235-0. Signal Transduct Target Ther. 2023. PMID: 36750721 Free PMC article.
Analyses of a chromosome-scale genome assembly reveal the origin and evolution of cultivated chrysanthemum.
Song A, Su J, Wang H, Zhang Z, Zhang X, Van de Peer Y, Chen F, Fang W, Guan Z, Zhang F, Wang Z, Wang L, Ding B, Zhao S, Ding L, Liu Y, Zhou L, He J, Jia D, Zhang J, Chen C, Yu Z, Sun D, Jiang J, Chen S, Chen F. Song A, et al. Among authors: liu y. Nat Commun. 2023 Apr 11;14(1):2021. doi: 10.1038/s41467-023-37730-3. Nat Commun. 2023. PMID: 37037808 Free PMC article.
Zanubrutinib in patients with previously treated B-cell malignancies intolerant of previous Bruton tyrosine kinase inhibitors in the USA: a phase 2, open-label, single-arm study.
Shadman M, Flinn IW, Levy MY, Porter RF, Burke JM, Zafar SF, Misleh J, Kingsley EC, Yimer HA, Freeman B, Rao SS, Chaudhry A, Tumula PK, Gandhi MD, Manda S, Chen DY, By K, Xu L, Liu Y, Crescenzo R, Idoine A, Zhang X, Cohen A, Huang J, Sharman JP. Shadman M, et al. Among authors: liu y. Lancet Haematol. 2023 Jan;10(1):e35-e45. doi: 10.1016/S2352-3026(22)00320-9. Epub 2022 Nov 16. Lancet Haematol. 2023. PMID: 36400069 Clinical Trial.
Spatial analysis of stromal signatures identifies invasive front carcinoma-associated fibroblasts as suppressors of anti-tumor immune response in esophageal cancer.
He JZ, Chen Y, Zeng FM, Huang QF, Zhang HF, Wang SH, Yu SX, Pang XX, Liu Y, Xu XE, Wu JY, Shen WJ, Li ZY, Li EM, Xu LY. He JZ, et al. Among authors: liu y. J Exp Clin Cancer Res. 2023 May 31;42(1):136. doi: 10.1186/s13046-023-02697-y. J Exp Clin Cancer Res. 2023. PMID: 37254126 Free PMC article.
Immunoregulation in cancer-associated cachexia.
Wu Q, Liu Z, Li B, Liu YE, Wang P. Wu Q, et al. Among authors: liu ye. J Adv Res. 2024 Apr;58:45-62. doi: 10.1016/j.jare.2023.04.018. Epub 2023 May 6. J Adv Res. 2024. PMID: 37150253 Free PMC article. Review.
1,686 results